Sutro Biopharma (STRO) announced the appointment of Greg Chow as CFO, effective June 2, 2025. Chow most recently served as Chief Financial and Business Officer at NodThera, where he played a key role in business development and financing activities.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STRO: